XML 44 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 209.5 $ 173.4
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 37.3 41.4
Amortization of debt issuance cost and debt discount 0.6 0.7
Unrealized gain on available-for-sale financial investments (0.4) (0.9)
Provision for accounts receivable credit losses 1.5 0.6
Benefit for deferred income taxes (1.7) (10.6)
Stock-based compensation expense 11.7 16.9
Impairment of property and equipment 0.3  
Gain from Cboe Digital syndication (0.4)  
Equity earnings in investments (12.8) (14.4)
Changes in assets and liabilities:    
Accounts receivable (40.7) (20.2)
Restricted cash and cash equivalents and customer bank deposits (included in margin deposits, clearing funds, and interoperability funds) 730.0 898.2
Income taxes receivable 67.7 43.8
Other current assets 1.2 (2.2)
Other assets (5.5) (8.4)
Accounts payable and accrued liabilities (113.5) (56.0)
Section 31 fees payable (9.2) (71.7)
Deferred revenue 7.0 9.9
Income taxes payable (1.1) 15.7
Unrecognized tax benefits 13.6 14.3
Other liabilities 0.5 0.3
Net cash provided by operating activities 895.6 1,030.8
Cash flows from investing activities:    
Contributions to investments (3.7) (2.1)
Purchases of available-for-sale financial investments (23.0) (48.8)
Proceeds from maturities of available-for-sale financial investments 20.6 64.4
Proceeds from sale of intangible assets   0.8
Proceeds from insurance 0.1  
Purchases of property and equipment and leasehold improvements (7.3) (12.4)
Net cash (used in) provided by investing activities (13.3) 1.9
Cash flows from financing activities:    
Cash dividends on common stock (58.5) (53.3)
Repurchases of common stock from employee stock plans (25.5) (12.7)
Payments of contingent consideration related to acquisitions (3.0) (4.9)
Shares issued under employee stock purchase plan (5.0) (0.3)
Purchase of common stock (76.6) (70.0)
Net cash used in financing activities (168.6) (141.2)
Effect of foreign currency exchange rates on cash, cash equivalents, and restricted cash and cash equivalents (25.0) 21.1
Increase in cash, cash equivalents, and restricted cash and cash equivalents 688.7 912.6
Cash, cash equivalents, and restricted cash and cash equivalents: Beginning of period 1,397.1 979.9
Cash, cash equivalents, and restricted cash and cash equivalents: End of period 2,085.8 1,892.5
Supplemental disclosure of cash transactions:    
Cash paid for income taxes, net of refunds 76.6 9.3
Cash paid for interest 17.4 $ 21.4
Supplemental disclosure of noncash financing activities:    
Unsettled purchases of common stock $ (12.7)